Asset Management One Co., Ltd. Ionis Pharmaceuticals Inc Transaction History

Asset Management One Co., Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 03, 2021	SELL	$34.54 - $47.25 $2.09 Million - $2.86 Million	-60,617 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $149,805 - $224,760	-3,524 Reduced 5.49%	60,617 $2.73 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $949 - $1,259	-20 Reduced 0.03%	64,141 $3.04 Million
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $20,895 - $27,228	-446 Reduced 0.69%	64,161 $3.78 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $53,081 - $80,898	-1,276 Reduced 1.94%	64,607 $3.05 Million
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $27,732 - $33,614	515 Added 0.79%	65,883 $3.98 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $160,879 - $196,536	2,724 Added 4.35%	65,368 $3.92 Million
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $3.89 Million - $5.4 Million	62,644 New	62,644 $4.03 Million

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.